Talk to the Veterans Crisis Line now
U.S. flag
An official website of the United States government

Health Services Research & Development

Go to the ORD website
Go to the QUERI website

HSR&D Investigator Leads AMA’s Most Viewed Discussion: Telemedicine Amid COVID-19

January 29, 2021


Takeaway: Michael Weiner, MD, MPH and colleagues conducted a virtual panel discussion titled, “Telemedicine Amid COVID-19,” for the American Medical Association (AMA) Physician Innovation Network in March and April 2020. Thus far, this is the most viewed discussion ever hosted on the AMA Network, with more than 95,000 views worldwide.

This virtual conversation covered many aspects of telemedicine as it was being rapidly deployed during the COVID-19 emergency. Key themes and findings identified during the discussion include:

  • Interest in the expansion of coverage for telemedicine and licensure across states and the expediting of the licensing process, as well as how organizations are supporting streamlined credentialing to quickly leverage additional resources. Physicians agreed that state licensure boundaries create actual care boundaries.
  • Asynchronous modes of telemedicine such as digital check-ins and remote patient monitoring and the key role they play for COVID-19 were discussed, along with how to manage chronic and low-risk conditions, and preventative care amid this pandemic.
  • Best practices relating to the implementation of telemedicine were addressed, including ensuring that all patients are educated and comfortable with the technology with which they will be communicating with their care providers.
  • Throughout the discussion, it became clear that there are gaps in patient-facing information and education on telehealth. Also identified were gaps in accessibility, equity, and privacy issues regarding telehealth and COVID-19 data.

Questions about the HSR&D website? Email the Web Team.

Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.